Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...
Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...
Connecticut COPD patients now have access to a new life-changing treatment in Hartford. The first patient at Saint Francis Hospital to get the procedure since it newly became available says it has ...
Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, today announced the publication of long ...
CHILLICOTHE— A new, minimally invasive procedure now being offered by Adena Health System for patients suffering from emphysema and COPD. “We’ve actually been talking about doing this type of ...
TEXARKANA, Texas -- A relatively new surgery is giving COPD and emphysema sufferers hope for better quality of life. Zephyr Endobronchial Valve treatment blocks areas of the lung that have been ...
Over 20,000 Patients Treated with the Non-Surgical Zephyr Valve for Severe Emphysema, a Form of COPD
REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx Corporation is announcing that over 20,000 patients have been treated worldwide with their Zephyr® ...
REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results